Symbols / PRVA Stock $23.50 -1.51% Privia Health Group, Inc.
PRVA (Stock) Chart
About
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It also offers technology and population health tools to enhance providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives. In addition, the company operates accountable care organization, which engages patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect across platform to better understand the holistic needs of each patient and connect with other providers to address individual medical needs. The company was founded in 2007 and is headquartered in Arlington, Virginia.
Stock Fundamentals
Scroll to Statements| Market Cap | 2.95B | Enterprise Value | 2.53B | Income | 22.92M | Sales | 2.12B | Book/sh | 5.96 | Cash/sh | 3.88 |
| Dividend Yield | — | Payout | 0.00% | Employees | 1226 | IPO | — | P/E | 130.56 | Forward P/E | 19.64 |
| PEG | — | P/S | 1.39 | P/B | 3.94 | P/C | — | EV/EBITDA | 57.42 | EV/Sales | 1.19 |
| Quick Ratio | 1.55 | Current Ratio | 1.60 | Debt/Eq | 1.21 | LT Debt/Eq | — | EPS (ttm) | 0.18 | EPS next Y | 1.20 |
| EPS Growth | 132.80% | Revenue Growth | 17.40% | Earnings | 2026-05-07 | ROA | 1.71% | ROE | 4.03% | ROIC | — |
| Gross Margin | 9.87% | Oper. Margin | 2.08% | Profit Margin | 1.08% | Shs Outstand | 125.62M | Shs Float | 111.02M | Short Float | 2.95% |
| Short Ratio | 2.85 | Short Interest | — | 52W High | 26.51 | 52W Low | 18.77 | Beta | 0.87 | Avg Volume | 855.83K |
| Volume | 682.22K | Target Price | $31.80 | Recom | Strong_buy | Prev Close | $23.86 | Price | $23.50 | Change | -1.51% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-04-08 | main | Evercore ISI Group | Outperform → Outperform | $26 |
| 2026-03-25 | main | Barclays | Equal-Weight → Equal-Weight | $25 |
| 2026-03-03 | main | Citigroup | Buy → Buy | $32 |
| 2026-03-02 | main | Truist Securities | Buy → Buy | $33 |
| 2026-02-27 | main | Canaccord Genuity | Buy → Buy | $35 |
| 2025-12-04 | reit | Stephens & Co. | Overweight → Overweight | $32 |
| 2025-11-13 | main | JP Morgan | Overweight → Overweight | $33 |
| 2025-11-13 | init | BMO Capital | — → Outperform | $30 |
| 2025-11-12 | main | Canaccord Genuity | Buy → Buy | $34 |
| 2025-11-10 | main | Barclays | Equal-Weight → Equal-Weight | $23 |
| 2025-11-10 | reit | Truist Securities | Buy → Buy | $31 |
| 2025-11-07 | main | Evercore ISI Group | Outperform → Outperform | $30 |
| 2025-11-07 | main | Citizens | Market Outperform → Market Outperform | $31 |
| 2025-10-09 | main | Barclays | Equal-Weight → Equal-Weight | $22 |
| 2025-09-24 | reit | Stephens & Co. | Overweight → Overweight | $32 |
| 2025-09-04 | reit | Stephens & Co. | Overweight → Overweight | $32 |
| 2025-08-29 | main | JMP Securities | Market Outperform → Market Outperform | $30 |
| 2025-08-11 | main | Piper Sandler | Overweight → Overweight | $35 |
| 2025-07-09 | main | Evercore ISI Group | Outperform → Outperform | $28 |
| 2025-05-28 | main | JP Morgan | Overweight → Overweight | $32 |
- Q4 Healthcare Technology for Providers Earnings: Privia Health (NASDAQ:PRVA) Earns Top Marks - StockStory hu, 23 Apr 2026 08
- Is Privia (PRVA) stock a good candidate for diversification | Q4 2025: EPS Tops Views - Cyclicality - Cổng thông tin điện tử tỉnh Tây Ninh hu, 23 Apr 2026 01
- (PRVA) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily hu, 23 Apr 2026 03
- Is Privia (PRVA) stock a good candidate for diversification | Q4 2025: EPS Tops Views - Community Risk Signals - Cổng thông tin điện tử tỉnh Lào Cai hu, 23 Apr 2026 00
- PRVA (Privia Health Group Inc.) posts strong Q4 2025 results with 22 percent year over year revenue growth, shares edge higher. - Profit Guidance - Xã Thanh Hà hu, 23 Apr 2026 11
- Is It Time To Reassess Privia Health Group (PRVA) After Mixed Returns And Rich P/E Ratio? - simplywall.st Fri, 17 Apr 2026 22
- Privia Health will post Q1 results before market open on May 7 - Stock Titan Wed, 08 Apr 2026 07
- $PRVA ($PRVA) Releases Q4 2025 Earnings - Quiver Quantitative hu, 26 Feb 2026 08
- 2 Profitable Stocks with Promising Prospects and 1 Facing Headwinds - The Globe and Mail ue, 21 Apr 2026 04
- PRVA (Privia) tops Q4 2025 EPS estimates by wide margin, 22.3 percent annual revenue growth lifts stock modestly. - Cổng thông tin điện tử tỉnh Tây Ninh hu, 23 Apr 2026 04
- PRVA (Privia Health Group Inc.) posts strong Q4 2025 results with 22 percent year over year revenue growth, shares edge higher. - Revenue Report - UBND thành phố Hải Phòng Wed, 22 Apr 2026 19
- Is Privia (PRVA) stock testing breakout levels (+2.21%) 2026-04-18 - Earnings Beat Stocks - Cổng thông tin điện tử tỉnh Lào Cai Sat, 18 Apr 2026 23
- Privia Health (PRVA) CFO sells shares to cover RSU tax obligations - Stock Titan Mon, 06 Apr 2026 07
- Healthcare Technology Stocks Q4 Recap: Benchmarking GoodRx (NASDAQ:GDRX) - StockStory Wed, 22 Apr 2026 09
- PRVA (Privia) tops Q4 2025 EPS estimates by wide margin, 22.3 percent annual revenue growth lifts stock modestly. - Crowd Risk Alerts - Cổng thông tin điện tử tỉnh Lào Cai Wed, 22 Apr 2026 17
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
2,122.84
+22.26%
|
1,736.39
+4.74%
|
1,657.74
+22.19%
|
1,356.66
|
| Operating Revenue |
|
2,113.66
+22.33%
|
1,727.84
+4.77%
|
1,649.23
+22.10%
|
1,350.71
|
| Cost Of Revenue |
|
1,913.41
+22.69%
|
1,559.54
+4.23%
|
1,496.24
+22.45%
|
1,221.88
|
| Reconciled Cost Of Revenue |
|
1,913.41
+22.69%
|
1,559.54
+4.23%
|
1,496.24
+22.45%
|
1,221.88
|
| Gross Profit |
|
209.43
+18.42%
|
176.85
+9.51%
|
161.50
+19.82%
|
134.78
|
| Operating Expense |
|
175.19
+9.59%
|
159.87
+13.50%
|
140.85
-8.48%
|
153.90
|
| Selling General And Administration |
|
165.29
+8.31%
|
152.60
+13.61%
|
134.32
-10.05%
|
149.33
|
| Selling And Marketing Expense |
|
27.14
+2.61%
|
26.45
+6.93%
|
24.73
+25.28%
|
19.74
|
| General And Administrative Expense |
|
138.15
+9.51%
|
126.16
+15.12%
|
109.59
-15.44%
|
129.59
|
| Other Gand A |
|
138.15
+9.51%
|
126.16
+15.12%
|
109.59
-15.44%
|
129.59
|
| Total Expenses |
|
2,088.61
+21.47%
|
1,719.41
+5.03%
|
1,637.09
+18.99%
|
1,375.78
|
| Operating Income |
|
34.23
+101.60%
|
16.98
-17.76%
|
20.65
+207.99%
|
-19.12
|
| Total Operating Income As Reported |
|
34.23
+101.60%
|
16.98
-17.76%
|
20.65
+207.99%
|
-19.12
|
| EBITDA |
|
44.14
+82.03%
|
24.25
-10.79%
|
27.18
+286.81%
|
-14.55
|
| Normalized EBITDA |
|
44.14
+82.03%
|
24.25
-10.79%
|
27.18
+286.81%
|
-14.55
|
| Reconciled Depreciation |
|
9.91
+36.31%
|
7.27
+11.25%
|
6.53
+42.92%
|
4.57
|
| EBIT |
|
34.23
+101.60%
|
16.98
-17.76%
|
20.65
+207.99%
|
-19.12
|
| Net Income |
|
22.92
+59.33%
|
14.38
-37.67%
|
23.08
+368.83%
|
-8.59
|
| Pretax Income |
|
43.94
+57.65%
|
27.87
-3.97%
|
29.02
+256.19%
|
-18.58
|
| Net Non Operating Interest Income Expense |
|
9.70
-10.88%
|
10.89
+30.05%
|
8.37
+1444.65%
|
0.54
|
| Interest Expense Non Operating |
|
—
|
—
|
—
|
—
|
| Net Interest Income |
|
9.70
-10.88%
|
10.89
+30.05%
|
8.37
+1444.65%
|
0.54
|
| Interest Expense |
|
—
|
—
|
—
|
—
|
| Tax Provision |
|
14.21
+31.28%
|
10.83
+35.44%
|
7.99
+222.67%
|
-6.52
|
| Tax Rate For Calcs |
|
0.00
-16.73%
|
0.00
+41.25%
|
0.00
-21.65%
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
29.73
+74.41%
|
17.04
-18.95%
|
21.03
+274.30%
|
-12.06
|
| Net Income From Continuing Operation Net Minority Interest |
|
22.92
+59.33%
|
14.38
-37.67%
|
23.08
+368.83%
|
-8.59
|
| Net Income From Continuing And Discontinued Operation |
|
22.92
+59.33%
|
14.38
-37.67%
|
23.08
+368.83%
|
-8.59
|
| Net Income Continuous Operations |
|
29.73
+74.41%
|
17.04
-18.95%
|
21.03
+274.30%
|
-12.06
|
| Minority Interests |
|
-6.81
-156.00%
|
-2.66
-229.64%
|
2.05
-41.05%
|
3.48
|
| Normalized Income |
|
22.92
+59.33%
|
14.38
-37.67%
|
23.08
+368.83%
|
-8.59
|
| Net Income Common Stockholders |
|
22.92
+59.33%
|
14.38
-37.67%
|
23.08
+368.83%
|
-8.59
|
| Diluted EPS |
|
0.19
+72.73%
|
0.11
-42.11%
|
0.19
+337.50%
|
-0.08
|
| Basic EPS |
|
0.19
+58.33%
|
0.12
-40.00%
|
0.20
+350.00%
|
-0.08
|
| Basic Average Shares |
|
122.18
+2.32%
|
119.40
+2.29%
|
116.73
+5.45%
|
110.70
|
| Diluted Average Shares |
|
128.89
+2.61%
|
125.61
+0.74%
|
124.69
+12.64%
|
110.70
|
| Diluted NI Availto Com Stockholders |
|
22.92
+59.33%
|
14.38
-37.67%
|
23.08
+368.83%
|
-8.59
|
| Depreciation Amortization Depletion Income Statement |
|
9.91
+36.31%
|
7.27
+11.25%
|
6.53
+42.92%
|
4.57
|
| Depreciation And Amortization In Income Statement |
|
9.91
+36.31%
|
7.27
+11.25%
|
6.53
+42.92%
|
4.57
|
| Total Other Finance Cost |
|
-9.70
+10.88%
|
-10.89
-30.05%
|
-8.37
-1444.65%
|
-0.54
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
1,369.38
+20.57%
|
1,135.78
+13.59%
|
999.90
+26.12%
|
792.81
|
| Current Assets |
|
911.00
+9.13%
|
834.82
+19.12%
|
700.80
+26.97%
|
551.96
|
| Cash Cash Equivalents And Short Term Investments |
|
479.69
-2.33%
|
491.15
+26.09%
|
389.51
+11.93%
|
347.99
|
| Cash And Cash Equivalents |
|
479.69
-2.33%
|
491.15
+26.09%
|
389.51
+11.93%
|
347.99
|
| Receivables |
|
400.90
+26.80%
|
316.18
+8.74%
|
290.77
+53.36%
|
189.60
|
| Accounts Receivable |
|
400.90
+26.80%
|
316.18
+8.74%
|
290.77
+53.36%
|
189.60
|
| Gross Accounts Receivable |
|
416.30
+27.90%
|
325.48
|
—
|
—
|
| Allowance For Doubtful Accounts Receivable |
|
-15.40
-65.59%
|
-9.30
|
—
|
—
|
| Prepaid Assets |
|
—
|
—
|
—
|
—
|
| Other Current Assets |
|
30.41
+10.62%
|
27.50
+33.96%
|
20.52
+42.87%
|
14.37
|
| Total Non Current Assets |
|
458.38
+52.30%
|
300.96
+0.62%
|
299.10
+24.18%
|
240.85
|
| Net PPE |
|
9.30
+53.18%
|
6.07
-32.08%
|
8.94
-22.12%
|
11.47
|
| Gross PPE |
|
16.84
+30.80%
|
12.88
-12.04%
|
14.64
-8.52%
|
16.00
|
| Accumulated Depreciation |
|
-7.54
-10.84%
|
-6.81
-19.36%
|
-5.70
-25.93%
|
-4.53
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
3.09
+0.00%
|
3.09
+0.00%
|
3.09
+0.95%
|
3.06
|
| Other Properties |
|
8.79
+82.15%
|
4.83
-26.98%
|
6.61
-18.26%
|
8.09
|
| Leases |
|
4.96
+0.00%
|
4.96
+0.43%
|
4.94
+1.73%
|
4.86
|
| Goodwill And Other Intangible Assets |
|
425.76
+69.34%
|
251.42
+2.05%
|
246.38
+33.67%
|
184.32
|
| Goodwill |
|
209.84
+48.18%
|
141.62
+2.07%
|
138.75
+9.30%
|
126.94
|
| Other Intangible Assets |
|
215.92
+96.64%
|
109.81
+2.02%
|
107.63
+87.55%
|
57.39
|
| Non Current Deferred Assets |
|
2.27
-91.38%
|
26.38
-25.05%
|
35.20
-12.80%
|
40.37
|
| Non Current Deferred Taxes Assets |
|
2.27
-91.38%
|
26.38
-25.05%
|
35.20
-12.80%
|
40.37
|
| Other Non Current Assets |
|
21.04
+23.17%
|
17.09
+99.13%
|
8.58
+83.22%
|
4.68
|
| Total Liabilities Net Minority Interest |
|
578.43
+27.88%
|
452.34
+15.24%
|
392.51
+43.38%
|
273.76
|
| Current Liabilities |
|
568.52
+26.58%
|
449.15
+16.07%
|
386.95
+46.42%
|
264.27
|
| Payables And Accrued Expenses |
|
63.25
+13.83%
|
55.57
+7.15%
|
51.86
+11.14%
|
46.66
|
| Payables |
|
7.97
-18.27%
|
9.76
-57.50%
|
22.95
+4.65%
|
21.93
|
| Accounts Payable |
|
7.97
-18.27%
|
9.76
+23.76%
|
7.88
+17.10%
|
6.73
|
| Other Payable |
|
—
|
20.42
+35.48%
|
15.07
-0.86%
|
15.20
|
| Current Accrued Expenses |
|
55.28
+20.67%
|
45.81
+58.50%
|
28.90
+16.89%
|
24.73
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
33.55
+26.99%
|
26.42
+342.32%
|
5.97
-3.30%
|
6.18
|
| Current Debt And Capital Lease Obligation |
|
2.20
-13.83%
|
2.55
-16.10%
|
3.04
+1.00%
|
3.01
|
| Current Debt |
|
—
|
—
|
—
|
—
|
| Other Current Borrowings |
|
—
|
—
|
—
|
—
|
| Current Capital Lease Obligation |
|
2.20
-13.83%
|
2.55
-16.10%
|
3.04
+1.00%
|
3.01
|
| Other Current Liabilities |
|
469.52
+28.77%
|
364.61
+11.82%
|
326.08
+56.45%
|
208.42
|
| Total Non Current Liabilities Net Minority Interest |
|
9.91
+210.82%
|
3.19
-42.62%
|
5.56
-41.42%
|
9.49
|
| Long Term Debt And Capital Lease Obligation |
|
7.33
+141.39%
|
3.04
-42.11%
|
5.25
-38.21%
|
8.49
|
| Long Term Debt |
|
—
|
—
|
—
|
—
|
| Long Term Capital Lease Obligation |
|
7.33
+141.39%
|
3.04
-42.11%
|
5.25
-38.21%
|
8.49
|
| Other Non Current Liabilities |
|
2.58
+1588.89%
|
0.15
-51.12%
|
0.31
-68.70%
|
1.00
|
| Stockholders Equity |
|
737.22
+16.06%
|
635.18
+13.14%
|
561.44
+12.49%
|
499.09
|
| Common Stock Equity |
|
737.22
+16.06%
|
635.18
+13.14%
|
561.44
+12.49%
|
499.09
|
| Capital Stock |
|
1.24
+2.74%
|
1.20
+1.78%
|
1.18
+2.96%
|
1.15
|
| Common Stock |
|
1.24
+2.74%
|
1.20
+1.78%
|
1.18
+2.96%
|
1.15
|
| Share Issued |
|
123.60
+2.74%
|
120.31
+1.77%
|
118.22
+3.07%
|
114.69
|
| Ordinary Shares Number |
|
123.60
+2.74%
|
120.31
+1.77%
|
118.22
+3.07%
|
114.69
|
| Additional Paid In Capital |
|
892.29
+9.72%
|
813.21
+7.87%
|
753.87
+5.49%
|
714.64
|
| Retained Earnings |
|
-156.31
+12.79%
|
-179.23
+7.43%
|
-193.61
+10.65%
|
-216.69
|
| Minority Interest |
|
53.73
+11.32%
|
48.26
+5.03%
|
45.95
+130.28%
|
19.95
|
| Total Equity Gross Minority Interest |
|
790.94
+15.73%
|
683.45
+12.52%
|
607.39
+17.02%
|
519.05
|
| Total Capitalization |
|
737.22
+16.06%
|
635.18
+13.14%
|
561.44
+12.49%
|
499.09
|
| Working Capital |
|
342.48
-11.20%
|
385.68
+22.88%
|
313.85
+9.09%
|
287.69
|
| Invested Capital |
|
737.22
+16.06%
|
635.18
+13.14%
|
561.44
+12.49%
|
499.09
|
| Total Debt |
|
9.53
+70.50%
|
5.59
-32.56%
|
8.29
-27.94%
|
11.50
|
| Capital Lease Obligations |
|
9.53
+70.50%
|
5.59
-32.56%
|
8.29
-27.94%
|
11.50
|
| Net Tangible Assets |
|
311.46
-18.84%
|
383.76
+21.81%
|
315.06
+0.09%
|
314.77
|
| Tangible Book Value |
|
311.46
-18.84%
|
383.76
+21.81%
|
315.06
+0.09%
|
314.77
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
163.40
+49.53%
|
109.28
+35.28%
|
80.78
+71.17%
|
47.20
|
| Cash Flow From Continuing Operating Activities |
|
163.40
+49.53%
|
109.28
+35.28%
|
80.78
+71.17%
|
47.20
|
| Net Income From Continuing Operations |
|
29.73
+74.41%
|
17.04
-18.95%
|
21.03
+274.30%
|
-12.06
|
| Depreciation Amortization Depletion |
|
9.91
+36.31%
|
7.27
+11.25%
|
6.53
+42.92%
|
4.57
|
| Depreciation |
|
0.74
-33.06%
|
1.10
-5.96%
|
1.17
-3.77%
|
1.22
|
| Amortization Cash Flow |
|
9.17
+48.73%
|
6.16
+15.02%
|
5.36
+59.92%
|
3.35
|
| Depreciation And Amortization |
|
9.91
+36.31%
|
7.27
+11.25%
|
6.53
+42.92%
|
4.57
|
| Amortization Of Intangibles |
|
9.17
+48.73%
|
6.16
+15.02%
|
5.36
+59.92%
|
3.35
|
| Other Non Cash Items |
|
—
|
—
|
—
|
0.69
|
| Stock Based Compensation |
|
71.07
+25.38%
|
56.68
+52.78%
|
37.10
-44.92%
|
67.36
|
| Deferred Tax |
|
10.87
+23.30%
|
8.82
+18.11%
|
7.46
+206.58%
|
-7.00
|
| Deferred Income Tax |
|
10.87
+23.30%
|
8.82
+18.11%
|
7.46
+206.58%
|
-7.00
|
| Change In Working Capital |
|
41.83
+114.82%
|
19.47
+124.84%
|
8.66
+236.33%
|
-6.35
|
| Change In Receivables |
|
-36.67
-84.97%
|
-19.82
+79.54%
|
-96.88
-34.17%
|
-72.20
|
| Changes In Account Receivables |
|
-36.67
-84.97%
|
-19.82
+79.54%
|
-96.88
-34.17%
|
-72.20
|
| Change In Prepaid Assets |
|
-1.60
+82.17%
|
-8.97
-45.64%
|
-6.16
-8.64%
|
-5.67
|
| Change In Payables And Accrued Expense |
|
14.82
-25.53%
|
19.91
+298.58%
|
4.99
-27.12%
|
6.85
|
| Change In Other Current Assets |
|
-0.33
+81.06%
|
-1.72
+28.83%
|
-2.42
-274.84%
|
1.38
|
| Change In Other Current Liabilities |
|
65.60
+118.07%
|
30.08
-72.43%
|
109.12
+72.43%
|
63.28
|
| Investing Cash Flow |
|
-181.57
-1415.86%
|
-11.98
+72.13%
|
-42.97
-41218.27%
|
-0.10
|
| Cash Flow From Continuing Investing Activities |
|
-181.57
-1415.86%
|
-11.98
+72.13%
|
-42.97
-41218.27%
|
-0.10
|
| Net PPE Purchase And Sale |
|
—
|
—
|
-0.11
-8.65%
|
-0.10
|
| Purchase Of PPE |
|
—
|
—
|
-0.11
-8.65%
|
-0.10
|
| Capital Expenditure |
|
—
|
—
|
-0.11
-8.65%
|
-0.10
|
| Net Business Purchase And Sale |
|
-180.37
-2492.64%
|
-6.96
+83.77%
|
-42.86
|
0.00
|
| Purchase Of Business |
|
-180.37
-2492.64%
|
-6.96
+83.77%
|
-42.86
|
0.00
|
| Net Other Investing Changes |
|
-1.20
+76.10%
|
-5.02
-4343.36%
|
-0.11
-8.65%
|
-0.10
|
| Financing Cash Flow |
|
6.70
+54.64%
|
4.33
+16.98%
|
3.71
+118.83%
|
-19.68
|
| Cash Flow From Continuing Financing Activities |
|
6.70
+54.64%
|
4.33
+16.98%
|
3.71
+118.83%
|
-19.68
|
| Net Issuance Payments Of Debt |
|
—
|
0.00
|
0.00
+100.00%
|
-33.25
|
| Issuance Of Debt |
|
—
|
—
|
—
|
0.00
|
| Repayment Of Debt |
|
—
|
0.00
|
0.00
+100.00%
|
-33.25
|
| Long Term Debt Issuance |
|
—
|
—
|
—
|
—
|
| Long Term Debt Payments |
|
—
|
0.00
|
0.00
+100.00%
|
-33.25
|
| Net Long Term Debt Issuance |
|
—
|
0.00
|
0.00
+100.00%
|
-33.25
|
| Short Term Debt Issuance |
|
—
|
—
|
—
|
0.00
|
| Short Term Debt Payments |
|
—
|
—
|
—
|
0.00
|
| Net Short Term Debt Issuance |
|
—
|
—
|
—
|
0.00
|
| Net Common Stock Issuance |
|
—
|
—
|
0.00
|
0.00
|
| Proceeds From Stock Option Exercised |
|
8.05
+200.15%
|
2.68
-69.32%
|
8.74
-35.01%
|
13.45
|
| Net Other Financing Charges |
|
-1.34
-181.37%
|
1.65
+132.83%
|
-5.04
-4128.00%
|
0.12
|
| Changes In Cash |
|
-11.46
-111.28%
|
101.64
+144.80%
|
41.52
+51.45%
|
27.41
|
| Beginning Cash Position |
|
491.15
+26.09%
|
389.51
+11.93%
|
347.99
+8.55%
|
320.58
|
| End Cash Position |
|
479.69
-2.33%
|
491.15
+26.09%
|
389.51
+11.93%
|
347.99
|
| Free Cash Flow |
|
163.40
+49.53%
|
109.28
+35.28%
|
80.78
+71.17%
|
47.20
|
| Interest Paid Supplemental Data |
|
0.25
-11.93%
|
0.28
+612.50%
|
0.04
-94.39%
|
0.71
|
| Income Tax Paid Supplemental Data |
|
6.64
+76.80%
|
3.75
+261.06%
|
1.04
+238.76%
|
0.31
|
| Common Stock Issuance |
|
—
|
—
|
0.00
|
0.00
|
| Issuance Of Capital Stock |
|
—
|
—
|
0.00
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-04-06 View
- 42026-03-18 View
- 42026-03-18 View
- 42026-03-16 View
- 42026-03-16 View
- 42026-03-12 View
- 42026-03-12 View
- 42026-03-12 View
- 42026-03-10 View
- 42026-03-10 View
- 42026-03-10 View
- 42026-03-02 View
- 42026-03-02 View
- 10-K2026-02-27 View
- 8-K2026-02-26 View
- 42025-12-16 View
- 42025-12-16 View
- 8-K2025-12-08 View
- 10-Q2025-11-06 View
- 8-K2025-11-06 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|